tradingkey.logo

Bio-Techne Corp

TECH
View Detailed Chart

50.350USD

-0.149-0.30%
Close 04/30, 16:00ETQuotes delayed by 15 min
7.95BMarket Cap
50.29P/E TTM

Bio-Techne Corp

50.350

-0.149-0.30%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.30%

5 Days

+0.38%

1 Month

-23.12%

6 Months

-31.73%

Year to Date

-30.10%

1 Year

-20.34%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 16 analysts
BUY
Current Rating
81.362
Target Price
61.11%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Bio-Techne Corp
TECH
16
CRISPR Therapeutics AG
CRSP
29
Regeneron Pharmaceuticals Inc
REGN
28
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Moderna Inc
MRNA
27
1
2
3
...
112

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(5)
Buy(1)
Indicators
Sell(1)
Neutral(5)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
1.492
Neutral
RSI(14)
37.434
Neutral
STOCH(KDJ)(9,3,3)
57.532
Neutral
ATR(14)
2.898
Low Volatility
CCI(14)
2.902
Neutral
Williams %R
45.969
Neutral
TRIX(12,20)
-1.241
Sell
StochRSI(14)
96.207
Overbought
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
50.386
Sell
MA10
49.767
Buy
MA20
51.384
Sell
MA50
64.249
Sell
MA100
68.891
Sell
MA200
71.880
Sell

News

More news coming soon, stay tuned...

Company

Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
Company codeTECH
CompanyBio-Techne Corp
CEOMr. Kim Kelderman
Websitehttps://www.bio-techne.com/